Successful novel use of dupilumab for gastrointestinal involvement of idiopathic hypereosinophilic syndrome: case report and review of the literature

By sjmartinez • September 12, 2024

Moffatt C, Soriano C, Dawson DW, Weiss GA. Successful novel use of dupilumab for gastrointestinal involvement of idiopathic hypereosinophilic syndrome: case report and review of the literature. Clin J Gastroenterol. 2024 Sep 11. doi: 10.1007/s12328-024-02036-4. Epub ahead of print. PMID: 39261360.

Tags: Digestive Diseases, Dupilumab, Eosinophilic enteritis, eosinophilic esophagitis, Eosinophilic gastritis, General Internal Medicine, Hypereosinophilic syndrome, Publications, Resident

MicroRNA Sequencing of Serum Exosomes Reveals miR205-5p as an Anti-Fibrogenic Factor Against Intestinal Fibrosis in Crohn’s Disease

Xie Y, van Daelen M, Park R, Almaraz I, Fontenot L, Rieder F, Ho W, Limketkai B, Shih DQ, Wei M, Li Y, Koon HW.[...]

De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease

Singh AK, Ainciburu M, Wynne K, Bhat SA, Blanco A, Tzani I, Akiba Y, Lalor SJ, Kaunitz J, Bourke B, Kelly VP, Doherty GA, Zerbe[...]

Vitamin C reduces gastric pH in pharmacologically induced hypochlorhydria: a potential approach for mitigating pH-dependent drug-drug interactions of weak-base drugs

Fadda HM, Shin A, Waseem MR, Camilleri M. Vitamin C reduces gastric pH in pharmacologically induced hypochlorhydria: a potential approach for mitigating pH-dependent drug-drug interactions[...]